AQST files Form 144 to sell 25,000 RSUs

AQST submitted a Form 144 reporting the proposed sale of 25,000 restricted stock units originally granted on 03/09/2024.

Rhea-AI Filing Summary

AQST submitted a Form 144 reporting the proposed sale of 25,000 restricted stock units originally granted on 03/09/2024. The filing also discloses a Rule 10b5-1 sale by Daniel R. Barber of 8,257 common shares on 05/15/2026 for $35,413.45.

Insights

Equity Compensation Counsel

Form 144 lists a resale of RSUs and a 10b5-1 disposition by an insider.

The filing records an intended resale of 25,000 restricted stock units granted 03/09/2024. It separately lists an executed 10b5-1 sale by Daniel R. Barber of 8,257 shares on 05/15/2026 for $35,413.45.

Cash‑flow treatment and any issuer proceeds are not stated in the excerpt; timing and methods for the RSU resale are described by the filing terms. Subsequent public filings may show completion or additional sales.

Key Figures

RSUs to be sold: 25,000 shares 10b5-1 shares sold: 8,257 shares Proceeds reported: $35,413.45 +1 more

4 metrics

RSUs to be sold 25,000 shares Grant date <date>03/09/2024</date>

10b5-1 shares sold 8,257 shares Sale date <date>05/15/2026</date>

Proceeds reported $35,413.45 Proceeds from 8,257-share 10b5-1 sale on <date>05/15/2026</date>

Form type Form 144 Filing reporting proposed resale and recent sales

Key Terms

Restricted Stock Units, 10b5-1, Form 144

3 terms

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 25000 | 03/09/2024"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for DANIEL R BARBER | Common | 05/15/2026 | 8257"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AQST's Form 144 report?

It reports the proposed resale of 25,000 restricted stock units (granted 03/09/2024) and a reported 10b5-1 sale of 8,257 shares on 05/15/2026 for $35,413.45. The filing lists transaction details but not proceeds treatment.

Who sold shares under the 10b5-1 plan in the AQST filing?

Daniel R. Barber is listed as executing a 10b5-1 sale of 8,257 common shares on 05/15/2026, generating $35,413.45 in proceeds as reported in the form excerpt.

How many RSUs is AQST seeking to resell in this filing?

The form lists the resale of 25,000 restricted stock units originally dated 03/09/2024. The excerpt identifies the RSU count and grant date but does not state whether sales have completed.

Does the Form 144 state whether AQST receives proceeds from the RSU sale?

The provided excerpt does not specify the cash‑flow recipient for the RSU resale. The form lists quantities and a separate 10b5-1 sale amount, but does not assign proceeds to the issuer or selling holder in the visible text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:38 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001742266
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aquestive Therapeutics, Inc.
SEC File Number	001-38599
Address of Issuer	30 Technology Drive Warren NEW JERSEY 07059
Phone	9089411900
Name of Person for Whose Account the Securities are To Be Sold	Daniel Barber
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	104250.00	125450119	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2024	Restricted Stock Units	Issuer			25000	03/09/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANIEL R BARBER 30 Technology Drive Warren NJ 07059	Common	05/15/2026	8257	35413.45

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel R Barber
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)